Cargando…
Targeting insulin-like growth factor axis in hepatocellular carcinoma
The insulin-like growth factor (IGF) axis contains ligands, receptors, substrates, and ligand binding proteins. The essential role of IGF axis in hepatocellular carcinoma (HCC) has been illustrated in HCC cell lines and in animal xenograft models. Preclinical evidence provides ample indication that...
Autores principales: | Wu, Jennifer, Zhu, Andrew X |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141798/ https://www.ncbi.nlm.nih.gov/pubmed/21729319 http://dx.doi.org/10.1186/1756-8722-4-30 |
Ejemplares similares
-
Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
por: Akiel, Maaged, et al.
Publicado: (2014) -
Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2015) -
Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2021) -
The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders
por: Blum, Werner F, et al.
Publicado: (2018) -
Insulin‑like growth factor axis: A potential nanotherapy target for resistant cervical cancer tumors (Review)
por: Morales-Rodríguez, Miguel, et al.
Publicado: (2023)